WaveMan · Form 4
Broadwood Capital INC insider trades
> Search tickers & screens ⌘K
LIVE

Broadwood Capital INC insider trades

Broadwood Capital INC has filed 13 Form 4s with the SEC that we hold, for Staar Surgical Co (STAA) (Director, 10% owner), Insight Molecular Diagnostics Inc. (IMDX) (10% owner) and Lineage Cell Therapeutics, Inc. (LCTX) (Director, 10% owner). Across all of them we count 37 purchases worth $75.8M and 0 sales worth $0 reported on Form 4. In the last 12 months: 6 purchases ($12.9M) and 0 sales ($0). The largest single trade was a purchase of 154,814 shares of Staar Surgical Co worth $6.1M, dated 2023-09-21. The first filing on our record is dated 2023-09-21 and the latest 2026-04-20.

Staar Surgical Co (STAA)

Director, 10% owner · 10 filings · 32 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-09-19P, purchase reported on Form 44,490$183.6K2023-09-21
2023-09-20P, purchase reported on Form 4132,079$5.4M2023-09-21
2023-09-21P, purchase reported on Form 4154,814$6.1M2023-09-21
2023-10-04P, purchase reported on Form 432,523$1.2M2023-10-06
2023-10-05P, purchase reported on Form 497,474$3.7M2023-10-06
2023-10-06P, purchase reported on Form 475,299$2.8M2023-10-06
2023-11-28P, purchase reported on Form 45,040$161.3K2023-11-30
2023-11-28P, purchase reported on Form 491,944$2.9M2023-11-30
2023-11-29P, purchase reported on Form 42,827$90.4K2023-11-30
2023-11-29P, purchase reported on Form 4157,473$4.9M2023-11-30
2023-11-30P, purchase reported on Form 4177,707$5.6M2023-11-30
2024-01-08P, purchase reported on Form 44,042$109.6K2024-01-10
2024-12-16P, purchase reported on Form 446,220$1.1M2024-12-18
2024-12-16P, purchase reported on Form 47,280$180.8K2024-12-18
2024-12-17P, purchase reported on Form 43,700$90.9K2024-12-18
2024-12-18P, purchase reported on Form 423,000$559.6K2024-12-18
2025-02-27P, purchase reported on Form 4114,713$1.9M2025-03-03
2025-02-27P, purchase reported on Form 4144,603$2.5M2025-03-03
2025-02-28P, purchase reported on Form 41,800$32.4K2025-03-03
2025-02-28P, purchase reported on Form 4153,142$2.7M2025-03-03
2025-03-03P, purchase reported on Form 418,974$330.7K2025-03-03
2025-03-03P, purchase reported on Form 4230,529$3.8M2025-03-03
2025-03-04P, purchase reported on Form 410,425$183.6K2025-03-06
2025-03-04P, purchase reported on Form 417,528$298.3K2025-03-06
2025-03-18P, purchase reported on Form 458,734$1.0M2025-03-20
2025-03-18P, purchase reported on Form 434,390$610.8K2025-03-20
2025-03-20P, purchase reported on Form 4108,720$2.0M2025-03-20
2025-03-21P, purchase reported on Form 4102,400$1.8M2025-03-25
2025-03-25P, purchase reported on Form 434,296$598.1K2025-03-25
2026-03-11P, purchase reported on Form 454,764$959.5K2026-03-13
2026-03-12P, purchase reported on Form 4299,432$5.4M2026-03-13
2026-03-13P, purchase reported on Form 4316,017$5.9M2026-03-13

Insight Molecular Diagnostics Inc. (IMDX)

10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-10-02P, purchase reported on Form 41,315,339$3.9M2024-10-04
2026-04-16P, purchase reported on Form 4102,057$352.1K2026-04-20
2026-04-17P, purchase reported on Form 440,114$143.2K2026-04-20
2026-04-20P, purchase reported on Form 440,690$157.9K2026-04-20

Lineage Cell Therapeutics, Inc. (LCTX)

Director, 10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2025-01-27P, purchase reported on Form 47,894,737$6.0M2025-01-28
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1278387) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms